Article

HHS Decides Not to Leapfrog to ICD-11

Word of the new ICD-10 compliance deadline came as welcome news to many in the healthcare realm — just not everyone.

There remains a corner of the industry that publicly asked the Department of Health and Human Services (HHS) to consider other alternatives, most notably ICD-11, before mandating a new deadline.

Read the full story: http://bit.ly/NAp9st

Source: Healthcare Finance News

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!
Related Videos
AJMC interview with Ali Shan Hafeez and Dr Abdul Rafae Faisal | Background image credit: ipopba - stock.adobe.com
2 experts in this video
2 experts in this video
Marry Vuong, PharmD, BCPPS
Julia Rotow, MD, Dana-Farber
Related Content
Doctor with stethoscope | Image credit: Ngampol - stock.adobe.com
August 1st 2025

Pivotal Studies in Cardiac Prevention Highlight Power of Cohorts

Julia Bonavitacola
Experts provided insights into how past cohort studies have helped to shape preventive medicine for more than 50 years.
The Center for Biosimilars podcast banner
August 1st 2025

Follow the Science: Bridging the Biosimilar Gap With Dr Hillel Cohen

Skylar Jeremias Hillel P. Cohen, PhD Giuseppe Randazzo
National Immunization Awareness Month. | Image Credit: design.designer - stock.adobe.com
August 1st 2025

5 Things Everyone Should Know for National Immunization Awareness Month

Cameron Santoro
National Immunization Awareness Month highlights the importance of lifelong vaccination to prevent diseases, a practice that has averted millions of deaths, proven to be a cost-effective public health strategy, and offers crucial protection even to individuals who are immunocompromised.
managed care cast logo
August 1st 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM
This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.
Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells
August 1st 2025

Prenatal PFAS Exposure Alters Infant Vaccine-Related Immune Cells

Alana Hippensteele, MA
Prenatal exposure to per- and polyfluoroalkyl substances (PFAS), a class of persistent environmental pollutants, was linked to significant shifts in infant T helper cell development, raising concerns about long-term effects on vaccine response, immune regulation, and disease susceptibility.
Though it would seem surprising for alopecia therapies with overlapping targets to lead to different patient outcomes, the authors said the evidence suggests the strategy can work. | Image credit: Nadya Kolobova - stock.adobe.com
August 1st 2025

New Strategies and Combinations Could Help Address AA Relapse

Jared Kaltwasser
Janus kinase inhibitors can be paired with corticosteroids or used as monotherapy in the treatment of alopecia areata.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo